Mutagenic and tumor suppressor functions of DNA polymerase iota in mammalian cells. by Stallons, Lindsey Jay, 1983-
University of Louisville 
ThinkIR: The University of Louisville's Institutional Repository 
Electronic Theses and Dissertations 
8-2008 
Mutagenic and tumor suppressor functions of DNA polymerase 
iota in mammalian cells. 
Lindsey Jay Stallons 1983- 
University of Louisville 
Follow this and additional works at: https://ir.library.louisville.edu/etd 
Recommended Citation 
Stallons, Lindsey Jay 1983-, "Mutagenic and tumor suppressor functions of DNA polymerase iota in 
mammalian cells." (2008). Electronic Theses and Dissertations. Paper 1370. 
https://doi.org/10.18297/etd/1370 
This Master's Thesis is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional 
Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator 
of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the author, who 
has retained all other copyrights. For more information, please contact thinkir@louisville.edu. 
MUTAGENIC AND TUMOR SUPPRESSOR FUNCTIONS OF DNA POLYMERASE 
IOTA IN MAMMALIAN CELLS 
8y 
Lindsey Jay Stallons 
8.S., UofL, 2006 
A Thesis 
Submitted to the Faculty of the 
Graduate School of the University of Louisville 
in Partial Fulfillment of the Requirements 
for the Degree of 
Master of Science 
Department of Pharmacology and Toxicology 
University of Louisville 
Louisville, KY 
August 2008 
Copyright 2008 by Lindsey Jay Stallons 
All rights reserved 
MUTAGENIC AND TUMOR SUPPRESSOR FUNCTIONS OF DNA POLYMERASE 
IOTA IN MAMMALIAN CELLS 
8y 
Lindsey Jay Stallons 
8.S., UofL, 2006 
A Thesis Approved on 
April 28, 2008 








This thesis is dedicated to my wife 
Mrs. Stacey Elaine Stallons 
who stands by me and supports me while I follow my dreams. 
iii 
ACKNOWLEDGMENTS 
I would like to thank my mentor, Dr. W. Glenn McGregor, for his guidance and 
support. I would also like to thank my other committee members, Drs. Jason Chesney, 
Ramesh Gupta, Christopher States, Brian Wattenberg, and Wolfgang Zacharias, for their 
insight into my project. Finally, I would like to thank Tom Burke for passing on his 
technical knowledge and contributing to the experiments described here. 
iv 
ABSTRACT 
MUTAGENIC AND TUMOR SUPPRESSOR FUNCTIONS OF DNA POLYMERASE 
IOTA IN MAMMALIAN CELLS 
Lindsey Jay Stallons 
August7,2008 
The Y family of DNA polymerases in higher eukaryotes contains at least four 
members which are implicated in potentially error-prone replication through unrepaired 
damage in the genome. These proteins are encoded by the REV1, POLH, POLl, and 
POLK genes. An inherited deficiency in one of these DNA polymerases (POLr)) is the 
molecular defect in the cancer prone xeroderma pigmentosum (XP) variant syndrome, 
making POLr) the most studied member of this family. However, there exist critical gaps 
in our knowledge on the function of the other known Y family members (POL I, POL K, 
and REV1). The goal of this proposal is to investigate the in vivo function of DNA POLl, 
and the hypothesis that DNA polymerase I acts as a mutagenic polymerase in 
translesion synthesis and as a tumor suppressor through a separate mechanism. To 
test this hypothesis, the mutagenic effects of chemical carcinogens which form 
structuallY different adducts will be examined in cells lacking POLr) and/or POLL To 
characterize the tumor suppressor function(s) of POLl, cell cycle progression will be 
monitored after UV in POLl null cells along with global gene expression. Finally, a novel 
mouse model will be used to determine the effect of polr) and/or poll deficiency on UV-
and chemically-induced skin cancer. 
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The Y family of DNA polymerases in higher eukaryotes contains at least four 
members that are implicated in potentially error-prone replication through unrepaired 
damage in the genome. These proteins are encoded by the REV1, POLfl, POLl, and 
POLK genes. An inherited deficiency in one of these DNA polymerases (POLI1) is the 
molecular defect in the cancer prone xeroderma pigmentosum (XP) variant syndrome, 
making POLI1 the most studied member of this family. However, there exist critical gaps 
in our knowledge on the function of the other known Y family members (POLl, POLK, 
and REV1). Our goal is to investigate the cellular function of DNA POLl, and we 
hypothesize that DNA polymerase I acts as a mutagenic polymerase in translesion 
synthesis and as a tumor suppressor through a separate mechanism. This hypothesis is 
based on the following observations. First, in vitro studies with purified POLl have 
characterized its error-prone bypass of damaged DNA templates. Second, our group 
and others have shown that POLl is active in error-prone bypass of UV damage in vivo. 
Third, PO/fl-/- po/,-/- double knockout mice develop tumors faster than PO/fl-/- po/i+/+ single 
knockouts despite having lower UV-induced mutation frequencies in their fibroblasts. 
Based on these observations, the focus of this thesis is on the cellular function of DNA 
POLL 
In Chapter 2, we will evaluate the mutagenic properties of chemical carcinogens 
in mammalian fibroblasts deficient for Y-family polymerases. We will examine the 
differential cytotoxic and mutagenic response of human and mouse fibroblasts with 
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decreased expression of POLl") and/or POLl to benzo[a]pyrene-7,8-diol-9,10-epoxide 
(BPDE), and N-acetoxy-2-acetylaminofluorene (AAAF). These chemicals form adducts 
at different positions in the DNA, and this Chapter is proposed to determine the cellular 
participation of each polymerase in bypassing chemically and structurally different DNA 
lesions. 
Chapter 3 is designed to investigate the tumor suppressor role of murine poll. 
We propose to test the hypothesis that poll functions as a tumor suppressor in mouse 
cells. Our group showed that mice that are deficient in both polf] and poll have lower 
UV-induced mutation frequencies, but strikingly develop tumors faster than mice that are 
deficient in polf] alone. This unexpected result is contrary to the somatic mutation 
hypothesis of cancer and implies that poll has tumor suppressor activity that may be 
independent of its mutagenic TLS activity. To investigate this, we propose to examine 
the effect of poll deficiency on miRNA, gene expression, and cell cycle checkpoints 
induced by UV or genotoxic carcinogens. 
Finally, we will characterize the effect of poll deficiency on in vivo skin 
tumorigenesis using a novel mouse model in Chapter 4. We hypothesize that deficiency 
in poll alone is sufficient to promote progression of skin cancer caused by UV and 
benzo[a]pyrene (B[a]P). Previous studies using C57BU6J mice required UV treatment 
for 20 weeks, after which neither wild type nor po/f/- animals developed tumors. Our 
novel mouse model introduces combinatorial polf] and poll knockouts into an 
SKH1/hairless xpa-l- background. These mice are nucleotide excision repair (NER)-
deficient and develop tumors after only 8 weeks of UV irradiation. Using established 
models of UV- and chemically-induced skin cancer, we will be able to identify any 
previously unobserved effects of poll deficiency alone and in combination with polf] 
deficiency during skin tumorigenesis. We will characterize the DNA damage and 
apoptotic response of epidermal cells in order to identify changes in these characteristics 
2 
due to proposed tumor suppression by poll. Finally, we will directly test the somatic 
mutation hypothesis of cancer by comparing in vitro mutagenesis results from Chapter 2 
with in vivo carcinogenesis results. 
Mutation and Cancer 
Mutagenesis is a recognized cornerstone of every form of human cancer[1;28] 
dating back to the discovery of aneuploidy in cancer cells[12]. According to the modern 
somatic mutation hypothesis of cancer, a cell must undergo several independent genetic 
and epigenetic events that together confer properties associated with the malignant 
phenotype. These include acquisition of infinite lifespan, resistance to apoptotic signals, 
growth factor independence, resistance to antigrowth signals, angiogenesis, and tissue 
invasion[32]. Acknowledgment of the critical role of mutations in carcinogenesis opens 
the possibility of chemoprevention using antimutator strategies. Although recent 
advances have elucidated key details of the pathways underlying mutagenesis, there 
exist critical gaps in our knowledge of the fundamental mechanisms by which DNA is 
mutated during carcinogenesis. In this thesis, we will investigate how environmental 
carcinogens permanently alter the sequence of DNA in order to cause cancer. 
Translesion Synthesis in Eukaryotes 
Recent evidence implicates DNA polymerase episilon (£) in leading strand DNA 
replication, and delta (5) in lagging strand[65]. When these enzymes encounter adducts 
that distort the helix, a variety of bypass mechanisms are initiated. This is particularly 
true of adducts in the leading strand template. The signals that initiate these responses 
are poorly understood at the present time, and constitute active areas of investigation in 
many laboratories including our own. It has been shown using a plasmid containing a 
site-specific acetylaminofluorene adduct that error-free damage avoidance accounts for 
more than 92% of lesion bypass, and that mutagenic translesion synthesis accounts for 
only 0.3% of bypass events[4]. It is clear from these studies that error-free homologous 
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recombination is the preferred method to resolve blocked replication forks in S. 
cere visia e, and experts in the field generally agree that these mechanisms are 
conserved in higher eukaryotic cells. Nevertheless, direct DNA synthesis past the lesion 
clearly occurs in all cells, and is the source of virtually all mutations induced by genotoxic 
carcinogens. This process is called translesion synthesis (TLS) and involves recruitment 
of Y-family DNA polymerases. The signaling cascade that initiates TLS is poorly 
understood. Data indicate that monoubiquitination of PCNA on K174 of each subunit is 
an early event that appears to promote interaction with REV1 and polll in yeast. This is 
also true of higher eukaryotic cells, but such cells have additional layers of complexity 
because they have two additional homologues (POLl and POLK) that are not present in 
yeast. The cell biology associated with these enzymes, which presumably act in concert 
with REV1 and polf'l, is the subject of this thesis. 
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Figure 1.1. Model for trans lesion synthesis. DNA damage causes arrest of the 
replication fork and recruitment of RAD6/RAD18 and REV1. Monoubiquitination of 
peNA facilitates recruitment of pol'l, poll, or pOlK to synthesize 1-2 nt directly past the 
lesion. Extension by pol~ leaves a suitable primer template for continued replication by 
polo or pol£. 
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Each of the V-family enzymes is characterized by an open active site that is 
capable of accommodating damaged DNA, but the costs of this unique capacity are 
fidelity and processivity[59]. REV1 is required for TLS in eukaryotes[30;4o], but appears to 
primarily playa structural role in recruiting other V-family polymerases to actively bypass 
the damage[54;s2]. Only 1-2 nt are inserted by poll1, I, or K before they dissociate from the 
DNA, allowing extension by pOh~[37;55], another critical TLS polymerase[4o;51]. This 
extended primer terminus is sufficient for continued replication by pol5 or £. Although in 
vitro studies using purified enzymes have addressed the kinetics of bypassing specific 
lesions by individual polymerases, we designed this project to fill critical gaps in our 
knowledge of the cellular roles of V-family polymerases. 
The most striking role for TLS in humans is in xeroderma pigmentosum variant 
(XPV) syndrome. XP patients are extremely prone to UV-induced skin cancer because 
cells from most patients are deficient in proteins of the nucleotide excision repair (NER) 
pathway, which is responsible for recognizing and removing structurally diverse adducts 
that distort the DNA helix. However, cells from a subset of XP patients were found to be 
NER-proficient, despite the fact that the individuals displayed the classical XP 
phenotype[49;73]. These patients were found to be deficient in DNA polymerase 11[35;44] 
and theirs are the most hypermutable known human cells in response to UV, despite the 
fact that NER actively repairs UV damage comparably to wild-type cells[77]. In vitro 
studies revealed that POLI1 replicates TT cyclobutane pyrimidine dimers, the most 
frequent lesions induced by UV, as faithfully as an undamaged TT template[36;43;44]. 
Hence, lack of POLI1 results in TLS past UV-induced lesions by more error-prone 
polymerases. Recently developed knockout mouse models have been used to examine 
the in vivo role of poll1 and poll in response to chronic UV exposure. polr( polt/+ mice 
were extremely susceptible to UV-induced skin cancer and their cells displayed a similar 
hypermutable phenotype to their human counterparts, validating the mouse model of 
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XPV[27;58]. Our group showed that fibroblasts from polr( pol1+ mice showed decreased 
UV-induced mutation frequency; however, these mice developed tumors about twice as 
fast as polr( poltl+ mice[27]. Deficiency in poll was also required for metastases and 
was associated with increased tumor burden[58]. These data suggest a role for poll as a 
tumor suppressor that is separate from its mechanism as a mutagenic polymerase, since 
deficiency in the enzyme decreased mutation frequency and yet increased tumor 
development and tumor burden. We will investigate the tumor suppressor role of poll in 
this project. 
Recruitment of V-Family Polymerases 
Previous reports showed that while POLry deficiency in human cells drastically 
increased the UV-induced mutation frequency, no effect was seen on mutagenesis 
induced by benzo[a]pyrene-7,8-diol-9,1 O-epoxide (BPDE)[78]. In contrast, recent studies 
by our group have shown that BPDE-induced mutation frequency is decreased in POLry·l. 
human and murine fibroblasts (see References). These results are consistent with 
reports of error-prone bypass of BPDE damage using purified pOI'l[87;88;92]. Along with 
the novel finding that pol'l acts in error-free bypass of UV damage and error-prone 
bypass of bulky BPDE lesions in live mammalian cells, our results suggest that the 
recruitment of Y -family polymerases to stalled replication fork is not dependent upon the 
lesion. Rather, we hypotheSize that pol'l is the primary TLS polymerase and is recruited 
to stalled replication forks first, and in its absence poll or pOlK would be allowed greater 
access to the lesion. We will examine this hypothesis in Chapter 2 using knockout 
models of pol'l and poll in response to treatment with chemically distinct genotoxicants. 
DNA Damage and Cell Cycle Checkpoints 
Environmental carcinogens such as benzo[a]pyrene, aminofluorene, and 
nitropyrene are metabolically activated and bind to DNA forming bulky, helix-distorting 
lesions[6;7;22;63;72]. These adducts are recognized and removed by nucleotide excision 
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repair[17;18;47;48]. However, if these adducts remain in the DNA when the cell enters S-
phase they pose a significant threat to genomic integrity: the DNA replication complex 
cannot replicate past such adducts in the template. Although the proximal signals are 
poorly understood at the present time, stalled replication forks activate cell cycle 
checkpoints, presumably to allow removal of the adducts. Checkpoints are complex 
signal transduction pathways that block cell cycle progression in response to DNA 
damage[93]. These pathways exist for G1, S, G2 and M phases to manage potential DNA 
damage throughout the cell cycle; the intra-S checkpoint is most relevant to this thesis. 
The molecular mechanisms underlying the activation of this checkpoint are not well 
understood. Available data indicate that stalled replication forks initiate the S-phase 
checkpoint by recruitment of the protein kinase A TR, and to a lesser extent the related 
protein ATM. ATR recruitment is dependent on a structural protein (ATR interacting 
protein) and may be initiated by extensive regions of single stranded DNA coated by 
RPA[95;96]. The downstream targets of phosphorylation by ATRlATM are myriad, and in 
this context are thought to promote degradation of cofactors that are required for 
progression through S-phase. 
It is of interest that bulky adducts induced by BPDE elicit an S-phase checkpoint 
in human lung carcinoma cells[31;79] that is dependent upon the Y-family polymerase K. 
A deficiency in this polymerase results in failure to recover from BPDE-induced S-phase 
arrest and causes double strand breaks, likely due to collapse of stalled replication 
forks[10]. This is the first direct evidence of cellular requirement for a translesion 
synthesis polymerase for cell cycle regulation, and supports the hypothesis that such 
polymerases are implicated in the activation of the intra-S-phase checkpoint. This 
hypothesis is strengthened by a recent report that human cells with significantly reduced 
expression of REV7 showed a decreased rate of S-phase progression after UV 
irradiation[50]. REV? is the non-catalytic partner of REV3 in the B-family polymerase 
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POLS, the first discovered TLS polymerase[56]. In Chapter 3, we propose to examine the 
hypothesis that the tumor suppressor function of poll is due to a similar function of this 
polymerase in activating cell cycle checkpoints. 
miRNA and Cancer 
miRNA are 20-22 base RNAs which negatively regulate gene expression by 
destabilizing target mRNAs. Initial transcription of miRNA genes yields larger primary 
miRNAs (pri-miRNAs) which are cropped by nuclear enzymes into -65nt hairpin-shaped 
precursors (pre-miRNAs). Pre-miRNAs are exported into the cytoplasm, where further 
processing yields a 22 nt duplex which complexes with the miRNA-induced silencing 
complex (miRISC). This complex can target other transcripts for degradation through 
perfect sequence complementarity in the 3' UTR of the target or, likely more common in 
animals, repress translation of targeted transcripts through indirect complementaritye;14]. 
miRNA gene expression patterns are greatly altered in many cancers, and several 
miRNAs are known to target oncogenes or tumor promoters (reviewed in [86]), making 
them strong candidates for cancer studies. It has been shown by our collaborators that 
the ubiquitous carcinogen BPDE alters miRNA gene expression profiles in small airway 
epithelial cells (unpublished observations). We hypothesize that poll status will alter 
miRNA gene expression changes induced by other carcinogens, including UV, and that 
these changes will provide insight as to the pathways effected by poll proficiency. 
Skin Cancer as a Tumorigenesis Model 
More than one million new cases of non melanoma skin cancer (NMSC) will be 
diagnosed in the U.S. in 2007, making it the most commonly diagnosed cancer in the 
country (American Cancer Society 2007 Facts and Figures). Ultraviolet radiation is the 
most ubiquitous carcinogen in the environment and is the primary etiological agent 
causing NMSC. Carcinogenesis from environmental UV exposure can be attributed to 
radiation ranging from 280 - 320 nm in wavelength (UVB), which generates 
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photoproducts in DNA capable of causing mutations. Short-wave UV (UVC) ranges from 
100 - 280 nm and is also highly carcinogenic, but is filtered out completely by 
atmospheric ozone and is thus not environmentally relevant. UVA is characterized by 
wavelengths between 320 - 400 nm and is only carcinogenic at much higher doses in 
mice compared to UVB due to absorption by cellular chromophores other than DNA and 
principle production of reactive oxygen species[9;52]. Ultraviolet radiation produces 
measurable effects in human and mouse skin. Trp53 is frequently mutated in UV-
induced mouse and human skin cancers[13;53], and this mutated tumor suppressor 
causes formation of precancerous clones in irradiated skin[8;38]. UV also induces a well 
characterized apoptotic sunburn response which appears to require wild type trp53. 
Sunburn cells are characterized by pycnotic nuclei and intensely eosinophilic cytoplasm, 
as well as DNA strand breaks[94]. We hypothesize that poll promotes p53 accumulation, 
cell cycle arrest, and apoptosis in its role as a tumor suppressor. 
Xeroderma pigmentosum (XP) has been described as a syndrome characterized 
by extreme predisposition to UV-induced skin cancer. The majority of patients have 
dysfunctional NER, resulting in faulty recognition and repair of helix distorting lesions 
including 6-4 photoproducts and cyclobutane pyrimidine dimers (CPO) induced by UV. 
Patients from XP complementation group A display the most severe phenotype, 
including extreme photosensitivity and neurological defects, and typically die of 
metastatic skin cancer early in life. Hairless mice that are homozygous xpa-I-, developed 
by Harry van Steeg, display a similar phenotype and are extremely susceptible to UV 
carcinogenesisC9] with a tumor latency of -10 weeks as compared to -1 year with Balb/c 
mice ([27] and unpublished observations). The van Steeg mice represent an excellent 
and well studied skin cancer model[19;21;26;66;74;75] and will be used in this thesis. 
Benzo[a]pyrene (B[a]P) is also a well studied skin carcinogen. It is clear that 
benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE), a metabolic derivative of B[a]P, is the 
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ultimate carcinogen[11;71]. BPDE formation proceeds through the action of CYP450, 
microsomal epoxide hydratase, and repeated CYP450 oxidation (reviewed in[62]). 
Carcinogenic activity of B[a]P is primarily due to in vivo binding of the ultimate 
carcinogen to DNA to form bulky adducts[71]. As analyzed by 32p-postlabeling, stable 
BPDE-N2-dG adducts constitute over 98% of adducts formed in mouse skin treated with 
anti-BPDEC6]. These adducts are normally recognized and repaired by enzymes in the 
NER pathway, and the NER-deficient mice we propose to use have been shown to 
accumulate more BPDE:DNA adducts than wild-type mice after B[a]P treatment[20]. 
These mice are also more sensitive to B[a]P-induced lung carcinogenesis[33], and 
represent an excellent model for chemical carcinogenesis. 
Acetylaminofluorene (AAF) is a well characterized model mutagen and liver, 
intestine, and urinary bladder carcinogen. AAF is subject to numerous metabolic 
activities in vivo that can result in formation of electrophilic intermediates capable of 
binding to DNA. N- and O-acetylation, hydroxylation, and sulfation all may lead to 
activation of the compound through many possible pathways[5]. Three major adducts 
are formed by AAF in vitro and in vivo and serve as NER substrates. AAF-C8-dG and 
AF-C8-dG form at differing ratios depending on cell type and activity of microsomal 
deacetylase[63]. AF-N2-dG is formed as a minor but persistent adduct in vivo[Bo] and is 
significantly less mutagenic than C8-dG adducts[84]. In mouse epidermal cells treated 
with the active metabolite N-acetoxy-2-acetylaminofluorene (AAAF), AF-C8-dG adducts 
make up over 90% of DNA adducts formed[63] 
Significance 
Our studies support a role for mouse poll in mutagenic translesion synthesis and 
in tumor suppression after UV exposure. In addition, limited available evidence indicates 
there may be differences in Y-family polymerase activities in response to UV and 
chemical damage. These areas represent critical gaps in our knowledge of mammalian 
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mutagenesis. We hypothesize that DNA polymerase I acts as a mutagenic polymerase 
in translesion synthesis and as a tumor suppressor through a separate mechanism. We 
propose to investigate the cellular roles of Y-family polymerases in order to further 
understanding of the mechanism of carcinogenesis by environmental agents with the 
ultimate aim of preventing cancer caused by these agents. 
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CHAPTER 2 
EVALUATE THE MUTAGENIC PROPERTIES OF CHEMICAL CARCINOGENS IN 
MAMMALIAN FIBROBLASTS DEFICIENT FOR Y-FAMIL Y POL YMERASES 
INTRODUCTION 
In this Chapter we will compare the cytotoxic and mutagenic properties of BPDE 
and AAF. BPDE is the ultimate genotoxicant metabolized from the ubiquitous 
carcinogen benzo[a]pyrene and primarily forms N2-dG adducts[15;69]. This carcinogen 
will be used in Chapter 4 for in vivo tumorigenesis studies. AAAF is the active 
metabolite of AAF and primarily adducts C8 of deoxyguanosine[57]. This Chapter will 
allow us to examine the hypothesis that structurally different chemical adducts have 
varying mutagenic activity when bypassed by V-family polymerases. We will also 
directly test the somatic mutation hypothesis of cancer by correlating in vitro 
mutagenesis data with in vivo tumorigenesis data collected in Chapter 4. 
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MATERIALS AND METHODS 
Cell lines to be used 
We used established NF1604, XP4BE, and XP115LO human cell lines as well as 
primary fibroblasts from knockout mice. NF1604 cells were isolated from normal fetal 
lung tissue, and XP4BE and XP115LO cells are from XP variant patients. All lines are 
stably transfected with a plasmid expressing human telomerase reverse transcriptase. 
This gives them an infinite lifespan, but they are otherwise normal[60]. polfJ knockout 
mice were recently generated by our collaborators in a C57BI/6 hybrid background[42]. 
To generate polfJ-1-po/f/- double knockouts, these animals were bred with 129/0la mice, 
which have been shown to carry a nonsense mutation in poll resulting in a protein 
truncated at Ser-27[45]. Primary fibroblasts have been isolated from these mice and 
used for mutagenesis studies in our laboratory[27], and these cells were used in this 
Chapter. Mouse fibroblasts were grown in monolayer cultures using a-MEM 
supplemented with non-essential amino acids, penicillin-streptomycin and 10% fetal 
bovine serum. They were maintained in exponential growth. We routinely grow primary 
murine cells in a 3% 02/5% C02/92% N2 atmosphere[61]. 
hprt mutagenesis 
For genotoxicant treatment, cells were plated at 1 x 104 cm-2. The culture media 
was removed and cells were washed twice with sterile phosphate-buffered saline (PBS, 
pH 7.4). Serum-free media was added to the cells along with each chemical carcinogen 
for a period of one hour. Doses of 0 - 250 nM BPDE and 0 - 2.0 IJM AAF were used for 
cytotoxicity studies. We used the dose giving -37% survival for mutagenesis studies. 
After one hour of treatment, the culture media was aspirated followed by two washes in 
PBS. For cytotoxicity, cells were trypsinized and counted, then replated at cloning 
density (the exact number depends on the expected survival). After two weeks, plates 
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were stained with 1 % crystal violet and counted. For mutagenesis, cells were 
maintained in exponential growth for eight days after treatment, after which we 
trypsinized, counted, and selected 1 X 106 cells with 40 IJM 6-thioguanine at a density of 
3000 cm-2. After 2 weeks of selection, we isolated individual TG r clones, trypsinized, 
and resuspended them in RNase-free PBS. The technique for amplifying the hprt gene 
was performed as described[83] with modifications routine in our laboratory[23]. Briefly, 
TGr colonies were pelleted at 4'C and the PBS removed. The cells were directly lysed 
and cDNA generated using a cDNA cocktail. After incubation at 37'C for 1 h 
amplification was performed using a Taq polymerase cocktail and two outer primers. The 
5' primer is from position -47 to -28 relative to the start codon (GGC TTC CTC CTC AGA 
GGG CT). The 3' primer is from position 790 to 771 (ACA TCA ACA GGA CTC CTC GT). 
Reamplification using an inner primer set (5', from -27 to -8, TTT TGC CGC GAG CCG 
ACC GG and 3', from 770 to 751, ATT TGC AGA TTC AAC TTG CG) will follow. The 
PCR products were sequenced with each of the inner primers using an ABI 370 
automated DNA sequencer and dRhodamine dye terminator chemistry. 
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RESULTS 
BPDE in Human Fibroblasts 
We treated POLr( XP115LO and wild type NF1604 human fibroblasts with 150 
or 200 nM BPDE and measured clonogenic survival and mutagenesis. These cells are 
isolated from an XP variant patient (XP115Lo) and normal fetal lung (NF1604) and are 
stably transfected with a plasmid expressing human telomerase reverse transcriptase. 
This gives them infinite lifespan, but they are otherwise normal[46;76]. After treatment and 
eight days of expression, cells were selected with 6-thioguanine (TG). Table 1 shows 
that XP variant fibroblasts are moderately sensitive to killing by BPDE, which is similar to 
the phenotype displayed by XP variant cells in response to UV[49]. However, unlike XPV 
cells after UV irradiation, XP115LO fibroblasts showed decreased mutation frequencies 
when compared to wild type NF1604 fibroblasts (Table 1). This novel result has been 
reproduced over three experiments using these cells and is consistent with published 
reports of in vitro error-prone TLS by purified human POLIl past BPDE-N2-dG DNA 
adducts[87;88;92]. Our results indicating POLIl in error-prone TLS of BPDE lesions 
contrasts with the known role of POLIl in error-free TLS past UV-induced lesions. Our 
conclusion that POLIl acts in error-prone bypass of BPDE lesions is also in sharp 
contrast with a report that POLIl is unresponsive to BPDE lesions in human POLr]"'" 
XP4BE cells[77]. We amplified and sequenced the HPRT gene from mutant colonies and 
found very little difference in the mutation spectrum, e.g. the types of mutations induced, 
of wild type NF1604 and POLl/" XP115LO fibroblasts (Table 2). The similarity in BPDE-
induced base substitution indicates that the enzyme acting to bypass the BPDE lesion in 
the absence of POLIl has a similar mutation spectrum for this adduct. 
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BPDE in Murine Fibroblasts 
To extend the results we obtained from studies of human cells, we performed 
similar experiments with primary murine fibroblasts deficient for pol'l, poll, or both. We 
first compared the sensitivity to BPDE of the cells using in situ cytotoxicity tests. For this 
method, cells were plated at cloning density and treated with varying doses of BPDE. 
Figure 2.1 displays the results of one experiment which show no apparent differences in 
the cytotoxicity of BPDE among the four cell lines, although significant sensitivity of polr,-
I· poll-!- double knockout cells may be shown after experimental replication. The dose 
resulting in 37% survival (D37) for each cell line was -100 nM. It is known from 
unpublished observations that mouse primary fibroblasts are more sensitive to 
genotoxicant treatments at low densities. It is for this reason that further cytotoxicity 
studies are performed by treating cells at 1 x 104 cells/cm2 and immediately replating at 
cloning density. This method of replating cytotoxicity accurately reflects the survival of 
cells treated at equal density for mutagenesis. Figure 2.2 shows the results of one or 
two replating cytotoxicity studies using 150 nM BPDE, the known D37 of wild-type 
primary murine fibroblasts at replating density. As in Figure 2.1, there are no obvious 
differences in sensitivity to BPDE treatment with the possible exception of the double 
knockout cells. Significantly, we used heterozygous polrtl- poltl+ cells for experiments 
shown in Figures 2.2 and 2.3. These cells were provided by a collaborator as 
homozygous polf] knockouts and were genotyped for confirmation of that only after 
these studies were completed. We have since verified by peR all genotypes indicated 
in this thesis. Strikingly, haploinsufficiency for polf] in these cells was sufficient to 
markedly reduce the mutation frequency induced by 150 nM BPDE as shown in Figure 
2.3. These results support our studies of human cells indicating POL'l in error-prone 
bypass of BPDE DNA adducts in contrast to its role in error-free bypass of UV damage. 
Similarly, polf]+I+ poll-!- fibroblasts showed drastically reduced mutation frequencies after 
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BPDE treatment, and polr( pol,-'- cells exhibited a 98% reduction in hprt mutations 
induced by 150 nM BPDE These results reflect the findings of in vitro studies which 
have characterized the error-prone bypass of BPDE-N2-dG DNA adducts, the major 
adduct induced by this carcinogen, by purified POLr) and POLI[67]. We hypothesize that 
the low mutation frequency of poll{ po,,-!- double knockout murine cells is due to error-
free lesion bypass by POlK, which has also been characterized in vitro[90;91]. 
AAAF in Murine Fibroblasts 
We examined the cytotoxic effects of N-acetoxy-2-acetylaminofluorene (AAAF) 
using replating cytotoxicity assays. This well characterized mutagen is a major 
metabolite of acetylaminofluorene, a carcinogen present in diesel exhaust, and 
predominantly forms AF-C8-dG adducts[63;64]. This lesion is structurally distinct from the 
N2-dG adduct which predominates after BPDE treatment, and the differences in 
cytotoxicity of the two chemicals are readily apparent in Figure 2.4. As compared to the 
very similar sensitivities of these cells to treatment with BPDE, poln and/or poll deficient 
murine fibroblasts appear to be more sensitive to killing by AAAF. The D37 calculated 
from these studies varies from 0.83 IJM for wild type cells to 0.16 IJM AAAF for poln-'-
polfl - double knockout cells_ This pattern of increased sensitivity is very similar to that 
characterized by our group after UV treatment of these cells[27], and supports a role for 
these enzymes in prevention of replication fork collapse and double strand break 
cytotoxicity. We hypothesize based on in vitro studies of purified yeast polr)[85] and 
human POLI[89] that polr) acts in error-free bypass of AAAF-induced DNA damage, while 
poll participates in error-prone TLS of the lesion. We will investigate this lesion-specific 
fidelity of cellular polr) and poll further in Chapter 4. 
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Experiment 1 2 3 
BPDE Dose (nM) 150 150 200 
1604 73 62 33 
Percent Survival 
XP115Lo 53 55 21 
Induced Mutants 1106 1604 263 208 483 
Clonable Cells XP115Lo 53 85 104 
Table 2.1. Cytotoxicity and mutagenesis of BPDE in human cells. Transformed human 
fibroblasts from normal (1604) or XP variant (XP115Lo) patients were treated with 150 or 




Transitions 8.3 8.7 
G>A 8.3 8.7 
Transversions 91.7 91.3 
G>T 58.3 69.6 
G>C 8.3 17.4 
A>T 25.0 4.3 
Table 2.2. BPDE-induced HPRT point mutations in human fibroblasts. Thioguanine-
resistant clones were isolated after BPDE treatment. HPRTmRNA was reverse 
transcribed and amplified by peR for sequencing. Numbers represent percentage of 
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Figure 2.1. Survival of murine fibroblasts after BPDE. Primary dermal fibroblasts 
isolated from mice of the indicated genotypes were treated with BPDE at cloning density 
and refed after one week. After two weeks, colonies were stained with crystal violet and 
counted to assay survival. It should be noted that these cells are more sensitive to 
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Figure 2.2. Suvival of murine fibroblasts after 150 nM BPDE. Primary dermal fibroblasts 
isolated from mice of the indicated genotypes were treated with BPDE at 10-4 cm-2 for 
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Figure 2.3. Mutagenesis after 150 nM BPDE. Primary dermal fibroblasts isolated from 
mice of the indicated genotypes were treated with 150 nM BPDE at 104 cm·2 . After eight 
days of exponential growth, cells were replated in 40 !-1M 6-thioguanine and grown for 
two weeks. Thioguanine-resistant clones were stained with crystal violet. Note that a 
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Figure 2.4. Cytotoxicity of AAAF in murine fibroblasts. Primary dermal fibroblasts 
isolated from mice of the indicated genotypes were treated with AAAF at 104 cm-2 for 
one hour and immediately replated at cloning density. Cells were refed after one week 
and stained with crystal violet after two weeks. 
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CONCLUSIONS AND FUTURE DIRECTIONS 
We conclude from these initial data that neither pair) nor poll is likely to contribute 
to cellular survival after BPDE treatment, although loss of pair) appears to make cells 
more sensitive to AAAF. Strikingly, we found that both paIr] and poll deficiency caused 
reduced mutation frequency after BPDE treatment in our primary dermal fibroblasts. 
This effect was also seen in human cells deficient for paIr]. This supports a role for both 
enzymes in error-prone, mutagenic bypass of BPDE:DNA lesions. This is confirmation 
of results using purified pair) and poll, but in contrast to published reports that pair] 
deficiency in human cells causes no change on BPDE-induced mutation frequency[77]. 
AAAF causes structurally distinct DNA lesions and appears to be more cytotoxic 
to murine cells deficient for paIr]. poll status did not appear to modulate AAAF 
sensitivity. These results are similar to the effect of deficiency for these enzymes on UV 
sensitivity[27], and we will investigate mutagenesis by this carcinogen at the hprt locus as 
we have for BPDE. We hypothesize based on in vitro experiments[85;89] that polr) 
participates in error-free bypass of AAAF damage and that poll is active in error-prone 




INVESTIGATE THE TUMOR SUPPRESSOR ROLE OF MURINE POL IOTA 
INTRODUCTION 
We have shown that poll deficiency in a polr( background causes decreased 
UV-induced mutation frequency and decreased UV-induced tumor latency[27], indicating 
a possible tumor suppressor role for the enzyme. It has been shown that poIK-1- mouse 
fibroblasts arrest in S-phase and display increased checkpoint signaling after treatment 
with BPDE and that recovery from this checkpoint is dependent upon pOlK. We propose 
to investigate the tumor suppressor role of poll in this Chapter, specifically focusing on 
cell cycle checkpoint signaling. We will also investigate differential miRNA and global 
gene expression responses to UV damage to determine the regulation of other genes 
and pathways by poll. 
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MATERIALS AND METHODS 
Irradiation protocol 
Cells were plated at cloning density (the exact number depends upon the 
expected survival) or 1 x 104 cm·2 and allowed to attach overnight. The culture medium 
was then be aspirated and cells will be exposed to 1 - 20 J/m·2 UVC. Culture medium 
was immediately replaced and cells were refed at one week and stained for counting 
and cytotoxicity determination at two weeks or harvested at various time points for 
analyses detailed below. 
Global gene expression 
In order to identify potential effects of poll expression on a larger scale, we 
examined the effects on global gene expression due to loss of pol'1, poli, or both in 
primary murine fibroblasts. This experiment was designed to discover the effect of poll 
deficiency on the expression of genes in known tumor suppressor or promoter pathways. 
Cells were irradiated with 20 Jcm·2 at 1 x 104 cm·2 and total RNA was extracted using the 
Qiagen miRNeasy kit. After amplification, resultant cDNA was transcribed using the 
GeneChip@ IVT Labeling Kit for hybridization on Affymetrix MOE 430_2.0 arrays using a 
GeneChip@ Scanner 3000 7G. Statistical analysis (ANOVA) of the microarray data was 
performed to evaluate significant changes between the groups with a q-Value <0.05 
using FDR (False Discovery Rate) multiple testing correction and Partek 6.1 software. 
We examined expression patterns associated with UV treatment, as well as differences 
in UV response between all cell lines. We randomly verified results using quantitative 
real-time PCR and Western Blots for affected proteins. 
miRNA microarrays 
To investigate the effect of poll deficiency on cancer-regulating miRNA 
expression, we analyzed global miRNA gene expression using a microarray-based 
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assay (LC Sciences). Total RNA samples isolated before and after UV treatment were 
enriched for miRNA, labeled with Cy3 or Cy5, and hybridized to a dual-color microarray 
chip. For this technique, the relative abundance of each miRNA in each sample was 
analyzed by the proportion of Cy3/Cy5 fluorescence at each probe site on the chip. 
Each chip contains six redundant probes for each of the known 568 mature mouse 
miRNAs. After background subtraction and data normalization, statistical correlation 
between the three chips representing independent biological replicates identified any 
miRNA genes altered between groups. As above, we analyzed data for UV-responsive 
miRNA and differences in UV response between cell lines. Results were randomly 
validated using Northern Slots and RT-PCR. 
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RESULTS 
To determine the potential mechanism by which poll acts as a tumor suppressor 
in mammalian cells, we examined UV-induced changes in global gene expression in 
polr( poltl+ and polr( poll-!- primary murine fibroblasts. Our group previously showed 
that polr( poll-!- fibroblasts get fewer mutations after UV exposure, but mice with this 
genotype have a decreased UV-induced tumor latency compared to the XPV model 
polr( poltl+ mice[27]. To examine the effect of poll deficiency on global gene expression, 
we plated cells at 1 x 104 cm·2 24 hr before treatment with 4 Jm·2 UVC. mRNA was 
isolated 24 hr after treatment, reverse transcribed into cDNA and amplified for global 
gene expression using Affymetrix Mouse Genome 430 2.0 GeneChip® arrays. For data 
analysis, we used a 2-way ANOVA incorporating cell line and treatment as well as their 
interaction as factors. The resulting p-Values were false discovery rate (FOR) corrected 
and cut off at a corresponding q-value of 0.05. Table 3 shows the 19 genes whose 
expression was modulated in different ways by treatment with UV between polr( poltl+ 
and polr( po/f/-cells. For example, protein tyrosine phosphatase receptor type V (ptprv) 
was the gene that showed the most statistically significant differential expression in the 
cell lines after UV exposure. In polr( poltl+ cells, UV induced a 1.56-fold upregulation of 
ptprv, while a 5.67-fold UV-induced upregulation was observed in polr(" po/f/- cells. This 
gene has only recently been characterized[41], but has already been linked to p53 
signaling, cell cycle checkpoints, and tumor suppression[24;25]. ADAMB (A Disintegrin 
And Metalloprotease 8) has been shown to be a possible diagnostic marker for lung 
cancer and renal cell carcinoma in humans[34;68] and is negatively correlated with 
prognosis in prostate, renal cell, and brain cancers[29;81]. Also relevant to this project is 
cdc20, which promotes progression through and exit from M phase and is often 
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overexpressed in malignancies[2;39]. These genes will provide an important basis for the 
investigation of the tumor suppressor role of poll. 
We also examined the effects of UV treatment on miRNA expression in these 
cells. Total RNA isolated after the treatment described above was enriched for miRNA 
and labeled with Cy3 or Cy5. Samples were hybridized in oppositely labeled pairs to two 
identical dual-color microarray chips containing probes for the 568 known mature 
miRNAs from the Sanger Database v1 0.0. Figure 3.1 shows results after background 
subtraction and data normalization. Expression of the miRNA listed was modulated after 
UV treatment. To our knowledge, this is the first evidence of altered miRNA expression 
after UV radiation in mammals. Using bioinformatics tools including the Sanger miRNA 
database for target mRNA prediction, we will be able to correlate miRNA expression 
data from all four cell lines to discover commonly affected tumor suppressor and 
promoter pathways altered by polt deficiency. 
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Name Description 
p- Fold Change Fold Change 
value (polTJ -/- poll +1+) (polTJ -/- poll-I-) 
PTPRV protein tyrosine phosphatase, 0.010 1.56 5.674 
receptor type, V (pseudoqene) 
ADAM8 ADAM metaliopeptidase domain 8 0.016 -1.01 1.557 
PMAIP1 phorbol-12-myristate-13-acetate- 0.018 2.21 24.246 
induced protein 1 
KIF23 kinesin family member 23 0.019 1.98 1.349 
solute carrier family 9 0.022 -1.18 1.229 
SLC9A3R (sodium/hydrogen exchanger), 
1 member 3 regulator 1 
ODZ3 odz, odd Ozlten-m homolog 3 0.023 -1.11 -3.631 
(Drosophila) 
PRKG1 protein kinase, cGMP-dependent, 0.026 -2.34 -4.339 
type I 
C80RF4 chromosome 8 open reading frame 0.037 2.69 1.362 
GST01 glutathione S-transferase omega 1 0.041 1.33 1.091 
CDC20 cell division cycle 20 homolog (S. 0.041 1.78 1.422 
cerevisiae) 
PC pyruvate carboxylase 0.042 1.28 1.697 
DGKA diacylglycerol kinase, alpha 80kDa 0.042 1.52 2.467 
RAD54L RAD54-like (S. cerevisiae) 0.042 1.63 1.308 
solute carrier family 9 0.044 -1.03 1.433 
SLC9A3R (sodium/hydrogen exchanger), 
2 member 3 regulator 2 
CRYAB crystallin, alpha B 0.045 2.80 1.678 
EFS embryonal Fyn-associated 0.045 2.83 5.238 
PAIP1 poly(A) binding protein interacting 0.048 1.30 -1.255 
protein 1 
KCNIP1 Kv channel interactinq protein 1 0.048 -1.30 -3.485 
MAN1A1 mannosidase, alpha, class 1 A, 0.050 1.12 1.398 
member 1 
Table 3.1. Differentially regulated, UV-responsive transcripts in primary murine 
fibroblasts. Dermal fibroblasts were treated with 4 Jm-2 and total RNA was isolated after 
24 hr. Affymetrix Mouse Genome 430 2.0 GeneChip arrays were used to quantify 
mRNA levels. UV-responsive mRNAs were identified using 2-way ANOVA incorporating 
cell genotype and treatment, as well as their interaction, as factors. The 19 genes 
shown here were differentially regulated by UV treatment between cells of the two 
genotypes. 
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Figure 3.1. UV-responsive miRNA. Primary dermal fibroblasts were treated with 4 Jm·2 
and total RNA was collected after 24 hr. After enrichment for small RNA, samples were 
labeled with either Cy3 or Cy5 and hybridized in oppositely labeled pairs to two identical 
dual-color microarray chips containing probes for mature murine miRNA from the Sanger 
Database v10.0. Two-way ANOVA was used to identify miRNAs with modulated 
expression after UV. 
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CONCLUSIONS AND FUTURE DIRECTIONS 
We have shown that UV radiation causes modulated mRNA and miRNA 
expression in our model system, primary dermal fibroblasts from mice. This is the first 
report of UV-responsive miRNA in mammalian cells. We have also shown that poll 
deficiency modulates both global gene and miRNA expression. We defined 19 genes 
that displayed differential UV modulation between polr{'- polt'+ and polr( pol{'- cells. We 
also defined mutually exclusive lists of nine and 11 miRNAs with modulated expression 
in polr( poll+i+ and polr( poll-!- cells, respectively. The readily apparent differences in 
gene expression in these cells supports our hypothesis that poll could act as a tumor 
suppressor by modulating gene expression. To further investigate this hypothesis we 
will validate our initial results using qRT-PCR and western blotting for target protein 
levels. 
In order to investigate cell cycle checkpoint activation after UV and the effects of 
poll deficiency, we will treat cells derived from mice deficient for polrl, poll, or both with 
UV and utilize FACS analysis of cell cycle progression. We will also examine levels of 
checkpoint proteins and their phosphorylated epitopes via westen blot to detect 
activation of G1/S and G2/M checkpoints after UV treatment. These will include chk1 
and chk2 along with phosphorylated epitopes chk1-phopho-Ser345 and chk2-phospho-
Thr68. We hypothesize that poll deficiency will promote cell cycle progression after UV 
damage, thereby promoting increased mutagenesis and/or chromosomal instability and 
promoting transformation of pOI(I- cells. 
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CHAPTER 4 
CHARACTERIZE THE EFFECT OF POL IOTA DEFICIENCY ON IN VIVO SKIN 
TUMORIGENESIS USING A NOVEL MOUSE MODEL 
INTRODUCTION 
In this Chapter we propose to generate a novel mouse model for TLS-mediated 
UV- and 8[a]P-induced skin cancer. This model is ideally suited for the hypothesis that 
poll acts as a tumor suppressor in vivo as we know that 100% of control SKH 1 /hairless 
xpa-I- mice will develop tumors after UV and chemical treatment. We hypothesize that 
deficiency in poll will result in decreased tumor latency after UV irradiation and 8[a]P 
carcinogenesis. Combined sunburn cell quantification and TUNEL assay will allow us to 
compare apoptosis in the epidermis of UV-irradiated mice. We hypothesize that poll 
deficiency will result in decreased levels of p53 and p21 activation and consequently 
decreased apoptosis, providing the basis for a tumor suppressor mechanism. We will 
also compare in vitro mutagenesis data using 8PDE from Chapter 2 with data from the 
8[a]P tumorigenesis experiment outlined in this Chapter. This will allow us to directly 
test the somatic mutation hypothesis of cancer and investigate chemical-induced tumor 
suppression by poll. 
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MATERIALS AND METHODS 
Mouse Model 
Previous studies used a combinatorial pol!} and poll knockout mouse model in a 
mixed 129/0la X C57BI/6 background. This model is not ideal for UV carcinogenesis 
studies for two reasons. First, the mice must be shaved twice weekly for UV treatment. 
Second, neither wild type nor pol!}+I+ poll';' mice develop tumors after 20 weeks of UV 
treatment. For this reason, we are backcrossing these mice into an SKH1/hairiess xpa·/· 
background. These mice were developed by Harry van Steeg and develop tumors after 
as few as 6 weeks of UV with an average latency of as little as 10 weeksC 9]. The UV-
induced cancer-prone phenotype of these mice will be an ideal background for 
elucidating the difference in skin cancer susceptibility between wild type and pol!}+1+ poll-!-
mice, which is critical for our hypothesis that poll acts as a tumor suppressor in vivo. To 
breed the mice, we back crossed C57BI/6 pol!}·/l42] and 129X1/SvJ (JAX), which are 
naturally pol{I.[45], with SKH1/hairiess xpa·/- mice. We monitored the hairless (hi) locus 
via screening for hairless pups at 4 weeks of age. We monitored xpaf1], pol!}t2], and 
pollt5] using published PCR-based screens and genomic DNA from tail snips. All mice 
from generation F2 will be screened for hrl- xpa·l. status as well as heterozygosity for the 
polymerase gene (pol!} or poll) and backcrossed into the SKHlIxpa-l. background for at 
least six generations[70]. Double knockout mice will be bred by crossing homozygous F7 
pol!}-I. pOll+l+ and pOI!}+I+ po/f/. mice to generate h(/- xpa·l. pOI!}+I- POII+I. animals. Doubly 
heterozygous littermates will be mated to obtain homozygous knockouts at all four loci. 
We have F2 pol!} mice and F2 poll mice in hand and expect to complete back crosses by 
fall 2008. 
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UV Irradiation protocol 
A control group of 40 SKH1/hairiess xpa-l- mice were segregated according to 
gender to prevent breeding over the course of the experiment and were housed in 
groups of five. The UV-8 irradiation source is a bank of seven fluorescent FS40 T12 
UV-8 sources (Westinghouse) that is placed -40 cm directly above the cages. (Pictures 
of the UV bed are included in Section F, Vertebrate Animals.) These lamps have a 
spectrum of 250-400 nm, peaking at -310 nm. The lamps were shielded with Kodacel, 
which removes any short wave UV below 280 nm. The fluence wass determined at 313 
nm using an International Light Radiometer with UV8-1 filter. The dorsal dose to the 
mice was 200 J/m2 per week, delivered in three exposures per week. This dose has 
been determined as the lowest exposure level causing mild erythema (the minimal 
erythema dose, MED) in our laboratory (unpublished observations). However, if the 
mice develop erythema, the UV fluence to all groups will be reduced. After 4, 6, 8, or 10 
weeks of such exposure, the UV irradiation was discontinued. The mice were examined 
weekly for tumor development and tumors were confirmed by two observations in which 
the volume of the tumor had increased. The mice were sacrificed if a tumor reached 




To determine the total UV dose necessary to ensure 100% of treated mice get 
tumors, we divided 20 male and 20 female SKH1/hairiess xpa-l- mice into four groups. 
Each group had five males and five females and was housed in groups of five 
segregated by sex. We irradiated the mice with a dorsal dose of 66 Jm,2 UVB three 
times weekly. Group one was irradiated for four weeks (total dose -800 Jm'2), group 
two for six weeks (total dose -1,200 Jm'2), group three for 8 weeks (total dose -1,600 
Jm'2), and group four for 10 weeks (total dose -2,000 Jm'2). One hundred percent of 
group three mice developed tumors with an average latency of -12 weeks (Figure 4.1). 
Accordingly, we decided to use the 1,600 Jm,2 cumulative dose over six weeks of UV 
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Figure 4.1. Tumor latency of SKH1/hairiess xpa-I- mice. Four groups of ten mice each 
were treated with 200 Jm-2 for the time periods indicated. Tumor growth was monitored 
weekly and mice were killed 20 weeks after treatment initiation. 
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Conclusions and Future Directions 
We have shown that SKH1/hairiess xpa-I - mice are an excellent model for skin 
cancer susceptibility due to the short latency of UV-induced cancers and the likelihood of 
100% of the mice developing cancer. We are currently back-crossing these mice with 
po/r( and po/f/-animals in order to examine the effects of deficiency for these genes on 
skin cancer risk. Using this mouse model, we will be able to identify any effects on UV-
induced skin cancer susceptibility due to poll deficiency alone, directly addressing our 
hypothesis. This has not been possible in previous studies in which neither pol/- nor 
wild-type mice developed cancer due to the NER-proficient wild type background of the 
animals. In addition to UV carcinogenesis, we will examine carcinogenesis by topical 
application of benzo[a]pyrene (B[a]P). This carcinogen forms bulky DNA adducts which 
our results show are bypassed in an error-prone way by both pol" and poll. We 
therefore hypothesize that mice deficient for these genes will have decreased incidence 
of B[a]P-induced skin cancer. 
In addition, we will examine the affects of acute UV and B[a]P exposure on the 
skin of these mice through histological analysis and immunohistochemical staining. By 
analyzing appearance of apoptotic and p53-positive cells, in addition to using the TUNEL 
assay, we will quantify cellular death in response to carcinogen treatment. We 
hypothesize that polt-deficient mice will display lower levels of cell death after UV, 
measured partially by the appearance of apoptotic "sunburn cells," in correlation with 
their proposed increased cancer risk. 
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